title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
"Earnings Scheduled For March 22, 2022",20220322T083557,https://www.benzinga.com/news/earnings/22/03/26233625/earnings-scheduled-for-march-22-2022,ERYP,0.0594,Neutral,-0.043487
"Why Muscle Maker Shares Are Trading Higher By 24%; Here Are 20 Stocks Moving Premarket - Audacy  ( NYSE:AUD ) , Ampio Pharmaceuticals  ( AMEX:AMPE ) ",20230511T122233,https://www.benzinga.com/news/23/05/32338822/why-muscle-maker-shares-are-trading-higher-by-24-here-are-20-stocks-moving-premarket,ERYP,0.148731,Neutral,-0.007973
96 Biggest Movers From Yesterday,20220315T085138,https://www.benzinga.com/news/22/03/26136650/96-biggest-movers-from-yesterday,ERYP,0.046412,Neutral,0.004789
96 Biggest Movers From Yesterday,20220315T085138,https://markets.businessinsider.com/news/stocks/96-biggest-movers-from-yesterday-1031280260,ERYP,0.023638,Neutral,0.00495
12 Health Care Stocks Moving In Monday's Intraday Session,20220314T182315,https://www.benzinga.com/intraday-update/22/03/26127603/12-health-care-stocks-moving-in-mondays-intraday-session,ERYP,0.073501,Neutral,0.003678
"Acute Lymphocytic Leukemia Market to Accelerate Substantially by 2032, Assesses DelveInsight | Key Companies in the Market - Beam, Pfizer, Genentech, AbbVie, Fate, Roche, Ascentage, Janssen, Jazz, ADC, Kymera, Syndax, ImmunoGen",20230913T210100,https://www.prnewswire.com/news-releases/acute-lymphocytic-leukemia-market-to-accelerate-substantially-by-2032-assesses-delveinsight--key-companies-in-the-market---beam-pfizer-genentech-abbvie-fate-roche-ascentage-janssen-jazz-adc-kymera-syndax-immunogen-301925772.html,ERYP,0.021897,Neutral,0.0
